Davis Hugh M. has filed 10 insider transactions across 1 company since December 2024.
Most recent transaction: a grant/award of 336300 shares of Aclaris Therapeutics, Inc. ($ACRS) on February 02, 2026.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb. 2, 2026 | Aclaris Therapeutics, Inc. | $ACRS | Davis Hugh M. | President and COO | A | Employee Stock Option (Right to Buy) | 336300 | $0.00 | 336,300.0000 | 122,564,741 | 9999.99% | 0.27% |
| Feb. 2, 2026 | Aclaris Therapeutics, Inc. | $ACRS | Davis Hugh M. | President and COO | A | Restricted Stock Units | 96100 | $0.00 | 96,100.0000 | 122,564,741 | 9999.99% | 0.08% |
| Feb. 3, 2026 | Aclaris Therapeutics, Inc. | $ACRS | Davis Hugh M. | President and COO | M | Common Stock | 18675 | $0.00 | 45,425.0000 | 122,564,741 | 69.81% | 0.02% |
| Feb. 3, 2026 | Aclaris Therapeutics, Inc. | $ACRS | Davis Hugh M. | President and COO | M | Restricted Stock Units | 18675 | $0.00 | 56,025.0000 | 122,564,741 | 25.00% | 0.02% |
| Dec. 2, 2025 | Aclaris Therapeutics, Inc. | $ACRS | Davis Hugh M. | President and COO | M | Restricted Stock Units | 26750 | $0.00 | 80,250.0000 | 122,619,311 | 25.00% | 0.02% |
| Dec. 2, 2025 | Aclaris Therapeutics, Inc. | $ACRS | Davis Hugh M. | President and COO | M | Common Stock | 26750 | $0.00 | 26,750.0000 | 122,619,311 | 9999.99% | 0.02% |
| Feb. 3, 2025 | Aclaris Therapeutics, Inc. | $ACRS | Davis Hugh M. | President and COO | A | Restricted Stock Units | 74700 | $0.00 | 74,700.0000 | 77,296,665 | 9999.99% | 0.10% |
| Feb. 3, 2025 | Aclaris Therapeutics, Inc. | $ACRS | Davis Hugh M. | President and COO | A | Employee Stock Option (Right to Buy) | 261600 | $0.00 | 261,600.0000 | 77,296,665 | 9999.99% | 0.34% |
| Dec. 2, 2024 | Aclaris Therapeutics, Inc. | $ACRS | Davis Hugh M. | President and COO | A | Restricted Stock Units | 107000 | $0.00 | 107,000.0000 | 71,381,731 | 9999.99% | 0.15% |
| Dec. 2, 2024 | Aclaris Therapeutics, Inc. | $ACRS | Davis Hugh M. | President and COO | A | Employee Stock Option (Right to Buy) | 375000 | $0.00 | 375,000.0000 | 71,381,731 | 9999.99% | 0.53% |